OptimizeRx Corp (OPRX) USD0.001

Sell:$12.25Buy:$13.50$0.58 (4.37%)

Prices delayed by at least 15 minutes
Sell:$12.25
Buy:$13.50
Change:$0.58 (4.37%)
Prices delayed by at least 15 minutes
Sell:$12.25
Buy:$13.50
Change:$0.58 (4.37%)
Prices delayed by at least 15 minutes

Company Information

About this company

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Key people

Stephen L. Silvestro
President, Chief Executive Officer, Director
Edward Stelmakh
Chief Financial Officer, Chief Operating Officer
Marion K. Odence-Ford
General Legal Officer and Chief Human Resources Officer
Doug Besch
Chief Product Officer and Chief Technology Officer
Theresa Greco
Chief Commercial Officer
Lynn O'Connor Vos
Independent Chairperson of the Board
Catherine M. Klema
Independent Director
James Lang
Independent Director
Patrick D. Spangler
Independent Director
Gregory D. Wasson
Independent Director
Click to see more

Key facts

  • EPIC
    OPRX
  • Location
    United States
  • Sector
    Services
  • Industry
    Advertising
  • ISIN
    US68401U2042
  • Market cap
    $250.42m
  • Employees
    106
  • Shares in issue
    20.24m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.